Literature DB >> 12788844

Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism.

Akiyo Tanabe1, Mitsuhide Naruse, Sachiko Takagi, Ken Tsuchiya, Toshihiro Imaki, Kazue Takano.   

Abstract

An increased plasma aldosterone concentration (PAC) with decreased plasma renin activity (PRA) is the abnormal endocrine finding in primary aldosteronism (PA). However, it remains unknown whether this profile is universal when blood samples are obtained in a random manner. We retrospectively evaluated the renin/aldosterone profile in 71 patients with PA due to unilateral adrenal adenoma. Blood samples were obtained randomly at an out-patient clinic and under standardized conditions during hospitalization before surgery. The frequency of PAC above 15 ng/dl, PRA below 0.5 ng angiotensin I/ml x h, and a PAC/PRA ratio greater than 35 was determined. These three variables showed a large intra- and interpatient variation. At least one measurement of PAC, PRA, and PAC/PRA ratio was in the normal range in 39%, 48%, and 31% of patients, respectively. Only 37% of patients always had the characteristic profile associated with PA. The mean values of PAC at the out-patient clinic were slightly, but significantly, lower than those in the hospital. These results clearly demonstrated that the renin/aldosterone profile in PA is not always abnormal due in part to conditions for blood sampling. We conclude that a single normal PAC, PRA, or PAC/PRA ratio does not excluded the diagnosis of PA in a hypertensive patient, but repeated measurements yields one or more abnormal parameters in the vast majority of patients. The PAC/PRA ratio is recommended to use as a screening, but other testing is required to arrive at the correct diagnosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788844     DOI: 10.1210/jc.2002-021476

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

1.  Effect of age on aldosterone/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups.

Authors:  Guoshu Yin; Shaoling Zhang; Li Yan; Muchao Wu; Mingtong Xu; Feng Li; Hua Cheng
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

Review 2.  Treatment of resistant hypertension.

Authors:  Sandra J Taler
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 3.  Primary aldosteronism: A contrarian view.

Authors:  Norman M Kaplan
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

Review 4.  Screening for adrenal-endocrine hypertension: overview of accuracy and cost-effectiveness.

Authors:  Gary L Schwartz
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

Review 5.  Primary aldosteronism, diagnosis and treatment in Japan.

Authors:  Yoshiyu Takeda; Shigehoro Karashima; Takashi Yoneda
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

Review 6.  Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.

Authors:  Laurence Amar; Pierre-François Plouin; Olivier Steichen
Journal:  Orphanet J Rare Dis       Date:  2010-05-19       Impact factor: 4.123

Review 7.  Primary Aldosteronism: a Continuum from Normotension to Hypertension.

Authors:  Taweesak Wannachalee; Adina F Turcu
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

8.  The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal masses.

Authors:  M Tzanela; G Effraimidis; G Effremidis; D Vassiliadi; A Szabo; N Gavalas; A Valatsou; E Botoula; N C Thalassinos
Journal:  Endocrine       Date:  2007-11-27       Impact factor: 3.633

9.  Unadjusted Plasma Renin Activity as a "First-Look" Test to Decide Upon Further Investigations for Primary Aldosteronism.

Authors:  Peter Rye; Alex Chin; Janice Pasieka; Benny So; Adrian Harvey; Gregory Kline
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-10       Impact factor: 3.738

Review 10.  Evolution of the Primary Aldosteronism Syndrome: Updating the Approach.

Authors:  Anand Vaidya; Robert M Carey
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.